UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Non-infectious comorbidity in patients with multiple sclerosis: A national cohort study in Sweden

Multiple sclerosis journal - experimental, translational and clinical, 2020-07, Vol.6 (3), p.2055217320947761-2055217320947761

2020

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and Pharmacodynamic Modeling of Recombinant Human Erythropoietin After Single and Multiple Doses in Healthy Volunteers

Journal of clinical pharmacology, 2004-09, Vol.44 (9), p.991-1002

2004

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic Considerations and Efficacy of Levofloxacin in an Inhalational Anthrax (Postexposure) Rhesus Monkey Model

Antimicrobial Agents and Chemotherapy, 2006-11, Vol.50 (11), p.3535-3542

2006

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial

Lancet neurology, 2019-11, Vol.18 (11), p.1009-1020

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial

Lancet neurology, 2019-11, Vol.18 (11), p.1021-1033

2019

Link zum Volltext

Verfügbarkeit prüfen

THE CAMZYOS (MAVACAMTEN) RISK EVALUATION AND MITIGATION STRATEGY PROGRAM: RESULTS FROM 10 MONTHS POST-LAUNCH

Journal of the American College of Cardiology, 2024-04, Vol.83 (13), p.354-354

2024

Link zum Volltext

Verfügbarkeit prüfen

Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis

Clinical gastroenterology and hepatology, 2021-03, Vol.19 (3), p.473-483.e17

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 12690: Mavacamten Treatment in Patients With Obstructive and Nonobstructive Hypertrophic Cardiomyopathy: A Pooled Safety Analysis of 5 Clinical Trials

Circulation (New York, N.Y.), 2022-11, Vol.146 (Suppl_1)

2022

Link zum Volltext

Verfügbarkeit prüfen

Design of DISCOVER-HCM: A Registry of Real-world Treatment Patterns and Outcomes of Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Journal of cardiac failure, 2024-01, Vol.30, p.S4

2024

Link zum Volltext

Verfügbarkeit prüfen

Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study

The lancet. Gastroenterology & hepatology, 2020-09, Vol.5 (9), p.819-828

2020

Link zum Volltext

Verfügbarkeit prüfen

Multi-database study of multiple sclerosis: identification, validation and description of MS patients in two countries

Journal of neurology, 2019-05, Vol.266 (5), p.1095-1106

2019

Link zum Volltext

Verfügbarkeit prüfen

S745 Safety of Concurrent Administration of Ozanimod and Serotonergic Antidepressants in Patients With Ulcerative Colitis

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S343-S343

2021

Link zum Volltext

Verfügbarkeit prüfen

Incident cardiovascular disease in patients diagnosed with multiple sclerosis: A multi-database study

Multiple sclerosis and related disorders, 2020-01, Vol.37, p.101423-101423, Article 101423

2020

Link zum Volltext

Verfügbarkeit prüfen

Infections in patients with multiple sclerosis: A national cohort study in Sweden

Multiple sclerosis and related disorders, 2020-10, Vol.45, p.102420-102420, Article 102420

2020

Link zum Volltext

Verfügbarkeit prüfen

Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial

Multiple sclerosis, 2022-10, Vol.28 (12), p.1944-1962

2022

Link zum Volltext

Verfügbarkeit prüfen

Lenalidomide (LEN) and Epstein-Barr Virus (EBV) Reactivation

Blood, 2015-12, Vol.126 (23), p.5372-5372

2015

Link zum Volltext

Verfügbarkeit prüfen

Incidence of Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV) Infections and Use of Prophylaxis in Lenalidomide-Treated Multiple Myeloma (MM) Patients (pts): An Analysis of MM Trials

Blood, 2014-12, Vol.124 (21), p.3451-3451

2014

Link zum Volltext

Verfügbarkeit prüfen

Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program

Multiple sclerosis and related disorders, 2021-06, Vol.51, p.102844-102844, Article 102844

2021

Link zum Volltext

Verfügbarkeit prüfen

False-positive pregnancy tests in females of reproductive potential receiving lenalidomide in the United States

Leukemia & lymphoma, 2018-04, Vol.59 (4), p.1025-1026

2018

Link zum Volltext

Verfügbarkeit prüfen

Peripheral Neuropathy (PN) with Immunomodulatory Drugs in Patients with Multiple Myeloma (MM)

Blood, 2016-12, Vol.128 (22), p.5677-5677

2016

Link zum Volltext

Verfügbarkeit prüfen

Incidence of venous thromboembolic events (VTE) in multiple myeloma patients receiving lenalidomide (LEN) with and without dexamethasone (DEX)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e18559-e18559

2012

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after multiple subcutaneous doses in healthy subjects

European journal of pharmaceutical sciences, 2005-11, Vol.26 (3), p.295-306

2005

Link zum Volltext

Verfügbarkeit prüfen

Global Implications of the EU’s Pharmacovigilance System Master File Requirements: Newly Developed Decision Trees to Distinguish Different Study Types

Pharmaceutical medicine, 2015-12, Vol.29 (6), p.323-329

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and pharmacodynamics of epoetin alfa once weekly and three times weekly

European journal of clinical pharmacology, 2001-08, Vol.57 (5), p.411-418

2001

Link zum Volltext

Verfügbarkeit prüfen

Treatment of theophylline overdose

The American journal of emergency medicine, 1996-10, Vol.14 (6), p.606-612

1996

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(56)
Buchkapitel
(1)

Sprache

Englisch
(57)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Non-infectious comorbidity in patients with multiple sclerosis: A national cohort study in Sweden

Pharmacokinetic and Pharmacodynamic Modeling of Recombinant Human Erythropoietin After Single and Multiple Doses in Healthy Volunteers

Pharmacokinetic Considerations and Efficacy of Levofloxacin in an Inhalational Anthrax (Postexposure) Rhesus Monkey Model

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial

THE CAMZYOS (MAVACAMTEN) RISK EVALUATION AND MITIGATION STRATEGY PROGRAM: RESULTS FROM 10 MONTHS POST-LAUNCH

Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis

Abstract 12690: Mavacamten Treatment in Patients With Obstructive and Nonobstructive Hypertrophic Cardiomyopathy: A Pooled Safety Analysis of 5 Clinical Trials

Design of DISCOVER-HCM: A Registry of Real-world Treatment Patterns and Outcomes of Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study

Multi-database study of multiple sclerosis: identification, validation and description of MS patients in two countries

S745 Safety of Concurrent Administration of Ozanimod and Serotonergic Antidepressants in Patients With Ulcerative Colitis

Incident cardiovascular disease in patients diagnosed with multiple sclerosis: A multi-database study

Infections in patients with multiple sclerosis: A national cohort study in Sweden

Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial

Lenalidomide (LEN) and Epstein-Barr Virus (EBV) Reactivation

Incidence of Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV) Infections and Use of Prophylaxis in Lenalidomide-Treated Multiple Myeloma (MM) Patients (pts): An Analysis of MM Trials

Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program

False-positive pregnancy tests in females of reproductive potential receiving lenalidomide in the United States

Peripheral Neuropathy (PN) with Immunomodulatory Drugs in Patients with Multiple Myeloma (MM)

Incidence of venous thromboembolic events (VTE) in multiple myeloma patients receiving lenalidomide (LEN) with and without dexamethasone (DEX)

Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after multiple subcutaneous doses in healthy subjects

Global Implications of the EU’s Pharmacovigilance System Master File Requirements: Newly Developed Decision Trees to Distinguish Different Study Types

Pharmacokinetics and pharmacodynamics of epoetin alfa once weekly and three times weekly

Treatment of theophylline overdose

Suchergebnisse filtern